Over 150 Total Lots Up For Auction at One Location - CA 05/31

Exo launches FDA-cleared AI on Exo Iris to address heart failure

Press releases may be edited for formatting or style | April 25, 2024 Ultrasound

With AI designed around the caregiver, questions like “Is my patient’s shortness of breath related to a heart condition or a lung condition?” can now be answered in a matter of seconds. With a quick scan, Exo’s lung AI reliably identifies the presence of B-lines, enabling users to quickly assess if the patient has pulmonary edema, or fluid in the lungs. Also, both expert and early POCUS users can leverage Exo’s cardiac AI to quickly measure left ventricle ejection fraction (LVEF) and stroke volume in a few heartbeats in both parasternal long axis (PLAX) and apical four-chamber (A4C) views. All these valuable data can be acquired and interpreted in real-time so that clinicians can improve patient care.

“Exo’s cardiac and lung AI applications are a game-changer,” said Ted Koutouzis, Clinical Instructor in Emergency Medicine at Northwestern Medicine. “Now I have a fast and reliable clinical tool to help easily distinguish between COPD and CHF patients for precise and timely care. What’s even more exciting is how these applications open ultrasound technology to a whole new set of POCUS users, especially those with limited experience. When clinicians can perform medical imaging efficiently, it’s a win-win for both the patients we serve and the healthcare systems we work within.”

In addition to cardiac and lung AI, Exo Iris now features Pulsed-Wave Doppler capabilities to provide physicians with even more opportunities to look at blood velocity to support diagnosis and deeper findings in cardiac, abdominal and vascular applications.

Unleashing a Pocket-Sized Imaging Ecosystem—Available for Online Purchase
Exo is on a mission to bring together a simple, affordable medical imaging ecosystem that fits right into a caregiver’s pocket. Exo’s revolutionary ecosystem includes Exo Iris, as well as a fast-growing suite of AI solutions and its award-winning POCUS workflow software, Exo Works®. Exo has made its ecosystem available for purchase on a new e-commerce channel for even easier access to simple, affordable medical imaging at the point of care.


About Exo
Exo, a medical imaging software and device company, believes everyone around the world should have access to immediate medical answers at the point of care. The company is on a mission to trailblaze new care pathways and modernize the medical landscape through its high-performance ultrasound platform and artificial intelligence, delivering high-quality, affordable and easy-to-use medical imaging to all caregivers. Exo’s ecosystem provides caregivers with instant answers to make critical decisions at the point of care to improve patient outcomes. For more information, please visit exo.inc. Follow us at @exoeffect on X, LinkedIn, Facebook and Instagram.

Back to HCB News

You Must Be Logged In To Post A Comment